WETO vs IVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 25, 2026

WETO

54.0
AI Score
VS
WETO Wins

IVF

48.4
AI Score

Investment Advisor Scores

WETO

54score
Recommendation
HOLD

IVF

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric WETO IVF Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -45.0% 16.7% IVF
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 54.0/100 48.4/100 WETO
Profit Margin -75.9% -92.3% WETO
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

WETO 1M: -90.1% · 3M: +97.9% IVF 1M: -10.3% · 3M: -61.2%

Current Technical Phase

WETO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 39.8 · Price: $1.71

IVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.7%), weak momentum, RSI 44

RSI (14): 44.3 · Price: $0.95

Fundamentals Snapshot

Metric WETO IVF
Market Cap — —
Forward P/E 0.0 -0.1
Trailing P/E — 0.0
Revenue (TTM) — —
Revenue Growth -0.5% 0.2%
Gross Margin 0.1% 0.4%
Operating Margin -1.2% -0.6%
EPS -13.00 361.31
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, WETO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.